1. Home
  2. LASR vs SVRA Comparison

LASR vs SVRA Comparison

Compare LASR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • SVRA
  • Stock Information
  • Founded
  • LASR 2000
  • SVRA 2007
  • Country
  • LASR United States
  • SVRA United States
  • Employees
  • LASR N/A
  • SVRA N/A
  • Industry
  • LASR Semiconductors
  • SVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • SVRA Health Care
  • Exchange
  • LASR Nasdaq
  • SVRA Nasdaq
  • Market Cap
  • LASR N/A
  • SVRA 505.8M
  • IPO Year
  • LASR 2018
  • SVRA N/A
  • Fundamental
  • Price
  • LASR $8.61
  • SVRA $3.22
  • Analyst Decision
  • LASR Strong Buy
  • SVRA Buy
  • Analyst Count
  • LASR 4
  • SVRA 6
  • Target Price
  • LASR $15.13
  • SVRA $8.83
  • AVG Volume (30 Days)
  • LASR 268.3K
  • SVRA 616.7K
  • Earning Date
  • LASR 05-08-2025
  • SVRA 05-16-2025
  • Dividend Yield
  • LASR N/A
  • SVRA N/A
  • EPS Growth
  • LASR N/A
  • SVRA N/A
  • EPS
  • LASR N/A
  • SVRA N/A
  • Revenue
  • LASR $198,548,000.00
  • SVRA N/A
  • Revenue This Year
  • LASR $8.26
  • SVRA N/A
  • Revenue Next Year
  • LASR $10.40
  • SVRA N/A
  • P/E Ratio
  • LASR N/A
  • SVRA N/A
  • Revenue Growth
  • LASR N/A
  • SVRA N/A
  • 52 Week Low
  • LASR $6.20
  • SVRA $2.26
  • 52 Week High
  • LASR $14.73
  • SVRA $5.31
  • Technical
  • Relative Strength Index (RSI)
  • LASR 60.32
  • SVRA 56.12
  • Support Level
  • LASR $7.88
  • SVRA $3.12
  • Resistance Level
  • LASR $8.60
  • SVRA $3.56
  • Average True Range (ATR)
  • LASR 0.33
  • SVRA 0.18
  • MACD
  • LASR 0.16
  • SVRA -0.02
  • Stochastic Oscillator
  • LASR 97.38
  • SVRA 55.11

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: